The U.S. has begun diverting airline passengers who have been to Uganda recently to five airports for health screenings, due to the Ebola outbreak. The health screenings will involve temperature checks, risk assessments and visual symptom checks. (POLITICO)

Researcher and former Johnson & Johnson head of R&D, Mathai Mammen, has emerged as Biogen’s top candidate for CEO. If Mammen is hired, it would signal a new direction for Biogen, which has previously hired corporate executives for the role of CEO rather than scientists. (STAT News)

Walgreens will begin selling Food and Drug Administration-approved over-the-counter hearing aids starting Oct. 17. The move will make it easier for people with mild to moderate hearing loss to access hearing aids. (MarketWatch)

BioMarin said it is laying off 120 employees, or 4% of its global workforce, to “simplify the organization.” The news comes as the FDA is reviewing BioMarin’s hemophilia A gene therapy, Roctavian. (Endpoints News)

Even with new drug pricing measures recently passed, Health and Human Services Secretary Xavier Becerra said more drug pricing efforts aren’t “off the table.” In particular, Becerra cited march-in rights — or the ability of the federal government to take over drug patents and license it to other manufacturers to reduce drug costs — as a potential effort to explore. (Axios)